sodium biphosphate-sodium phosphate
| Form | Strength |
|---|---|
| ENEMA, RECTAL | 3.5 g-9.5 g (Ped) 7 g-19 g (Adult) |
| SOLUTION, ORAL | 45 mL |
| Hierarchy in guiding laxative use |
|---|
| 1. Docusate |
| 2. Miralax if docusate ineffective |
| 3. Dulcolax PO if Miralax ineffective; Dulcolax PR if patient unable to tolerate PO |
| 4. Milk of magnesia if Dulcolax ineffective |
| 5. Mag citrate if Milk of Magnesia ineffective |
| 6. Fleets Enema if Mag citrate ineffective |
| Pediatric Pharmacy Association 2025 KIDs List of Key Potentially Inappropriate Drugs in Pediatrics | |
|---|---|
| Medication: | sodium phosphate solution enema, rectal (Fleet) |
| Key Potentially Inappropriate Drugs in Pediatrics (KIDs) List: Second Edition (Table 1) | |
| Drug | sodium phosphate solution enema, rectal |
| Risk/Rationale | Electrolyte abnormalities, acute kidney injury, arrhythmia, death |
| Recommendation | Avoid in younger than 2 yr |
| Quality of evidence: High, Strength of Recommendation: Strong | |